Back to Search

Research on Clear Cell Carcinoma of the Cervix

Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

Recruiting Observational Study
Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Observational
Participants needed
70 (estimated)
Sponsor
M.D. Anderson Cancer Center · Other
Who this trial is looking for

This trial is looking for patients diagnosed with clear cell carcinoma of the cervix at MDACC. By participating, you’ll help researchers learn more about this condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with clear cell carcinoma of the cervix.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with clear cell carcinoma of the cervix at MDACC
Contacts

No contact information available.

NCT ID: NCT05046080 Source: ClinicalTrials.gov